IP50-09: A Time Toxicity Analysis of BCG and Sequential Gemcitabine and Docetaxel for Non-Muscle-Invasive Bladder Cancer
Sunday, May 17, 2026 7:00 AM to 9:00 AM · 1 hr. 59 min. (America/New_York)
146A
Abstract
Speakers
Melinda Fu
ResidentRutgers RWJRegistered attendees
Scott Flanders
VP of Medical AffairsImmunityBio, Inc.